International Meeting on Cancer Chemoprevention: molecular basis, mechanisms and trials.
作者信息
Bartsch H, Frank N, Gerhäuser C, Owen R W, Berger M R
机构信息
Division of Toxicology and Cancer Risk Factors, Deutsches Krebsforschungszentrum, Heidelberg, Germany.
出版信息
Eur J Cancer Prev. 1997 Feb;6(1):80-92. doi: 10.1097/00008469-199702000-00013.
Abstract
摘要
相似文献
1
International Meeting on Cancer Chemoprevention: molecular basis, mechanisms and trials.国际癌症化学预防会议：分子基础、机制与试验
Eur J Cancer Prev. 1997 Feb;6(1):80-92. doi: 10.1097/00008469-199702000-00013.
2
3
Molecular epidemiologic methods in cancer chemoprevention.癌症化学预防中的分子流行病学方法。
Eur J Cancer Prev. 1996 Dec;5 Suppl 2:19-25. doi: 10.1097/00008469-199612002-00003.
4
How should we move the field of chemopreventive agent development forward in a productive manner?我们应该如何以富有成效的方式推动化学预防剂开发领域向前发展？
Recent Results Cancer Res. 2005;166:113-24. doi: 10.1007/3-540-26980-0_9.
5
Recent advances in chemoprevention of cancer.癌症化学预防的最新进展。
Science. 1997 Nov 7;278(5340):1073-7. doi: 10.1126/science.278.5340.1073.
6
Risk biomarkers and current strategies for cancer chemoprevention.癌症化学预防的风险生物标志物及当前策略。
J Cell Biochem Suppl. 1996;25:1-14.
7
Biomarkers as intermediate end points in chemoprevention trials.
J Natl Cancer Inst. 1990 Apr 4;82(7):555-60. doi: 10.1093/jnci/82.7.555.
8
Cancer chemoprevention.癌症化学预防
BMJ. 2002 Mar 23;324(7339):714-8. doi: 10.1136/bmj.324.7339.714.
9
Cancer risk factors for selecting cohorts for large-scale chemoprevention trials.用于大规模化学预防试验的队列选择的癌症风险因素。
J Cell Biochem Suppl. 1996;25:29-36.
10
Progress in cancer chemoprevention: perspectives on agent selection and short-term clinical intervention trials.癌症化学预防的进展：药物选择及短期临床干预试验的观点
Cancer Res. 1994 Apr 1;54(7 Suppl):2015s-2024s.
Zotero 插件